Abstract:Transoral Robotic Surgery (TORS) has become widely adopted for the surgical removal of oropharyngeal squamous cell carcinoma (OPSCC), with the most common locations being in the tonsil and base of tongue (BOT). However, it is currently unknown if TORS has equal efficacy and outcomes in patients with tonsillar or BOT OPSCC. Therefore, the aim of this study was to compare the margin status and recurrence rates of tonsillar and BOT OPSCC after TORS. Per PRISMA guidelines, PubMed, Scopus, and CINAHL were systemati… Show more
“…While the anatomic subsite of head and neck cancers is an important general consideration, it is also important to recognize potential challenges of anatomic sites within the oropharyngeal designation. The article by Poupore evaluates the efficacy of transoral robotic surgery of the tonsil versus the base of the tongue by evaluating margin status, recurrence, and complication rates [ 11 ]. While there was a higher rate of positive margins in the base of the tongue, there was no difference in locoregional or metastatic recurrence rates between these subsites.…”
“…While the anatomic subsite of head and neck cancers is an important general consideration, it is also important to recognize potential challenges of anatomic sites within the oropharyngeal designation. The article by Poupore evaluates the efficacy of transoral robotic surgery of the tonsil versus the base of the tongue by evaluating margin status, recurrence, and complication rates [ 11 ]. While there was a higher rate of positive margins in the base of the tongue, there was no difference in locoregional or metastatic recurrence rates between these subsites.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.